Related Experiment Videos
Successful use of cardiac allograft from serotonin antagonist intoxication
G Tenderich1, A Dagge, U Schulz
1Heart and Diabetes Center North Rhine-Westfalia, Department of Thoracic and Cardiovascular Surgery, Ruhr-University of Bochum, Georgstrasse 11, D-32545 Bad Oeynhausen, Germany.
Insights
Donor hearts from certain antidepressant overdose victims can be safely used for heart transplantation (HT), potentially reducing organ shortages. Reevaluating donor criteria is crucial to expand the donor pool for critically ill patients.
Area of Science:
- Cardiology
- Transplantation Medicine
- Toxicology
Background:
- Increasing demand for heart transplantation (HT) faces a critical shortage of suitable donor organs.
- Current donor criteria exclude many potential donors, including those with intoxication history.
- Expanding donor eligibility could alleviate organ scarcity.
Observation:
- A case report details a successful orthotopic heart transplant using an allograft from a donor deceased due to antidepressant overdose.
- Graft function was assessed post-transplant.
Findings:
- Early graft function was satisfactory, with echocardiography showing an ejection fraction of 75% and minor anteroseptal dyskinesis.
- The recipient experienced some postoperative gastrointestinal complications but recovered well.
- The patient was discharged from intensive care after 4 days and hospital stay was 26 days.
Implications:
- Hearts from select antidepressant intoxication victims may be viable for HT due to limited myocardial toxicity.
- Revising current cardiac organ donor criteria is essential to maximize the available organ pool.
- This approach could significantly benefit patients awaiting heart transplants.
Background:
Compromised organ donors are generally not accepted for heart transplantation (HT) despite the increasing number of critically ill patients on the waiting lists. By extending the donor criteria to include certain cases of intoxication, the organ shortage may be reduced.
Methods:
The case of a successful orthotopic HT with an allograft from a donor poisoned by antidepressant overdose is presented.
Results:
Early graft function was satisfactory with anteroseptal dyskinesis and an ejection fraction of 75% on echocardiography. The cardiac allograft recipient suffered some postoperative complications including gastrointestinal problems. The following period was up to now uneventful. Discharge from the intensive care unit was after 4 days. In-hospital stay was prolonged at 26 days.
Conclusions:
Because of limited myocardial toxicity, donor hearts from certain victims of antidepressant intoxication may be safely used for HT. Existing cardiac organ donor criteria must be reevaluated to maximise the available organ pool.